Elite Pharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$45.37 M |
Shares Outstanding |
828.89 M |
Public Float |
745.59 M |
Address |
165 Ludlow Avenue Northvale New Jersey 07647 United States |
Employees | - |
Website | http://www.elitepharma.com |
Updated | 07/08/2019 |
Elite Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology, as it relates to abuse resistant products. Its strategy includes off-patent drug products for life cycle management and developing generic versions of controlled-release drug products. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ. |